Relay Therapeutics to Participate in Two Upcoming Investor Conferences in September
Provided By GlobeNewswire
Last update: Aug 28, 2025
CAMBRIDGE, Mass., Aug. 28, 2025 (GLOBE NEWSWIRE) -- Relay Therapeutics, Inc. (Nasdaq: RLAY), a clinical-stage, small molecule precision medicine company developing potentially life-changing therapies for patients living with cancer and genetic disease, today announced that management will participate in two upcoming fireside chats in September:
Read more at globenewswire.com
